Chris Learn Email & Phone Number

Sr. Vice President, Cell and Gene Therapy Center of Excellence @ Parexel

View Chris's Email & Phone Number

5 free lookup(s). No credit card required.

If you need more lookups, subscriptions start at $34 USD/month.

Chris Learn Location

Chapel Hill, NC, US

Chris Learn Work

Sr. Vice President, Cell and Gene Therapy Center of Excellence @ (March 2022 - Present)
Board Member @ (October 2024 - Present)
Sr. Director, Clinical Development @ (February 2021 - March 2022)
Sr. Director, Cell and Gene Therapy, Therapeutic Science and Strategy Unit @ (May 2019 - January 2021)
CAR-T Principal, Oncology and Hematology @ (April 2016 - May 2019)
Sr. Clinical Scientist, Oncology @ (September 2015 - April 2016)
Sr. Clinical Project Manager and Therapeutic Compound Lead, Oncology @ (January 2008 - September 2015)
Sr. Clinical Scientist, Research Division @ (April 2007 - December 2007)
Industry Research Fellowship, Department of Computational Biology @ (April 2006 - May 2007)
Associate in Research, Division of Neurosurgery, Department of Surgery @ (January 2001 - April 2006)

Chris Learn Education

NC State Poole College of Management
🎓 Master of Business Administration (Marketing)
Wake Forest Biomedical Graduate Programs
🎓 Ph. D. (Microbiology and Immunology)
Virginia Tech
🎓 Bachelor of Science in Biology (Minor in Chemistry - Graduated Summa Cum Laude)

Chris Learn Skills

Adverse Event Reporting
Biochemistry
Biology
Biomarker Development
Biomarker Discovery
Biomarkers
Biotechnology
Board & Investor Reporting
Board Level
Breast Cancer
Brochure Development
Budget Oversight
Budgetary Responsibilities
Business Development
CAR-T & Adoptive Cell Therapy
CRO
CTMS
Cancer Genomics
Cancer Immunotherapy
Cell & Gene Therapy Clinical Development
Center of Excellence Development
Clinical
Clinical Data Management
Clinical Development
Clinical Protocol & CSR Authoring
Clinical Research
Clinical Trials
Computational Biology
Corporate Training
Cross-Functional & Matrix Leadership
Cross-Functional Liaison
Cross-functional Team Leadership
Data Analysis
Database Administration
Department Of Health
Diagnostic Development
Drug Development
Employee Training
Endoscopy
Executive Leadership
FDA
FDA Engagement & Breakthrough Designation Strategy
Financial Analysis
GCP
GCP & GMP Compliance
Gene Expression
Gene Expression Profiling
Global Clinical Trial Operations
Global Program Management
Global Team Leadership
Go-to-Market Strategy
Growth Strategies
HIV/AIDS
Immuno-Oncology Strategy
Immunogenetics
Immunologist
Immunology
Immunotherapy
Issue Resolution Management
Life Sciences
Managing Partners
Marketing Education
Medical Microbiology
Oncology
Operations Research
P&L Management
PMP
Patient Recruitment
Pediatric Hematology/Oncology
Pharmaceutical Industry
Pharmaceutical process development
Planning Budgeting & Forecasting
Policies & Procedures Development
Portfolio Management
Probability
Product Launch
Program & Portfolio Management
Program Development
Program Oversight
Project Management Professional
Protocol
Public Speaking
Quality Control
Regulatory Agencies
Regulatory Development
Regulatory Science
Regulatory Strategy & Submissions (IND/BLA)
Revenue Growth & Market Share Expansion
Risk Identification & Mitigation
SOP
Scientific Publications & Thought Leadership
Site Management
Strategic Planning for Growth
Succession Planning & Talent Development
Team Facilitation
Team Training & Mentorship
Timeline Management
Transfection
Venture Capital

Chris Learn Summary

Chris Learn, based in Chapel Hill, NC, US, is currently a Sr. Vice President, Cell and Gene Therapy Center of Excellence at Parexel. Chris Learn brings experience from previous roles at Cory Heidaran Charitable Foundation (CHCF), Istari Oncology, IQVIA and ICON plc. Chris Learn holds a 🎓 Master of Business Administration in Marketing @ NC State Poole College of Management. With a robust skill set that includes Adverse Event Reporting, Biochemistry, Biology, Biomarker Development, Biomarker Discovery and more. Chris Learn has 2 emails and 1 mobile phone numbers on RocketReach.